References
1. Coca AF, Cooke RA. On the classification of the phenomena of hypersensitiveness. J Immunol 1923;8:163–182.
2. Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab 2015;66(1):8–16.
3. Lee YU, Park SH, Nam EH, Chung TH, Hwang CY. Modulatory effects of PG102 (Actinidia arguta) on inflammatory cytokine mRNA expression in canine atopic dermatitis. Thai J Vet Med 2016;46(4):601–607.
4. Marco M, Heeney D, Binda S, Cifelli CJ, Cotter PD, Foligne B, et al. Health benefits of fermented foods: microbiota and beyond. Current Opinion in Biotechnology 2017;44:94–102.
5. Um YR, Lee JH, Ma JY. Quantitative analysis of marker substances in Solid fermented Angelicae Gigantis Radis by HPLC. Korean Journal of Oriental Medicine 2010;16(1):173–178.
6. Wickman M, Asarnoj A, Tillander H, Andersson N, Bergstrom A, Kull I, et al. Childhood-to -adolescence evolution of IgE antibodies to pollens and plant foods in the BAMSE cohort. J Allergy Clin Immunol 2014;133(2):580–582.
7. Westman M, Asarnoj A, Hamsten C, Wickman M, van Hage M. Windows of opportunity for tolerance induction for allergy by studying the evolution of allergic sensitization in birth cohorts. Seminars in Immunology 2017;30:61–66.
8. Peng W, Novak N. Pathogenesis of atopic dermatitis. Clinical & Experimental Allergy 2015;45:566–574.
9. Bieber T. Atopic Dermatitis. Ann Dermatol 2010;22:125–137.
10. Kasutani K, Fujii E, Ohyama S, Adachi G, Hasegawa M, Kitamura H, Yamashita N. Anti-IL-31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice. Br J Pharmacol 2014;171:5049–5058.
11. Mu Z, Zhao Y, Liu X, Chang C, Zhang J. Molecular biology of atopic dermatitis. Clin Rev Allergy Immunol 2014;47:193–218.
12. Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization. J Allergy Clin Immunol 2004;113:832–836.
13. Ong PY, Leung DY. Immune dysregulation in atopic dermatitis. Curr Allergy Asthma Rep 2006;6:384–389.
14. Leung DY, Boguniewicz M, Howell M, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest 2004;113:651–657.
15. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136(7):2348–2357.
16. Maggi E, Prete GD, Macchia D, Parronchi P, Tiri A, Chrétien I, et al. Profiles of lymphokine activities and helper function for IgE in human T cell clones. Eur J Immunol 1988;18:1045–1052.
17. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, et al. Predominant TH2-like bronchoalveolar Tlymphocyte population in atopic asthma. N Engl J Med 1992;326:298–304.
18. Chan LS, Robinson N, Xu L. Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J Invest Dermatol 2001;117:977–983.
19. Pulendran B, Artis D. New paradigms in type 2 immunity. Science 2012;337:431–435.
20. Hirano T. Interleukin 6 and its receptor: 10 years later. Int Rev Immunol 1998;16:249–284.
21. Diehl S, Rincón M. The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol 2002;39(9):531–36.
22. Danso MO, van Drongelen V, Mulder A, van Esch J, Scott H, van Smeden J, et al. TNF-a and Th2 Cytokines Induce Atopic Dermatitis - Like Features on Epidermal Differentiation Proteins and Stratum Corneum Lipids in Human Skin Equivalents. Journal of Investigative Dermatology 2014;134:1941–1950.
23. Cameron DJ, Tong Z, Yang Z, Kaminoh J, Kamiyah S, Chen H, et al. Essential role of Elovl4 in very long chain fatty acid synthesis, skin permeability barrier function, and neonatal survival. Int J Biol Sci 2007;3:111–119.
24. van Smeden J, Janssens M, Kaye EC, Caspers PJ, Lavrijsen AP. The importance of free fatty acid chain length for the skin barrier function in atopic eczema patients. Exp Dermatol 2014;23:45–52.
25. Zhu Z, Oh M-H, Yu J, Liu YJ, Zheng T. The Role of TSLP in IL-13-induced atopic march. Sci Rep 2011;1:23.
26. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: The control of NF-kB activity. Annu Rev Immunol 2000;18:621–663.
27. Aupperle K, Bennett B, Han Z, Boyle D, Manning A, Firestein G. NF-k B regulation by I k B kinase-2 in rheumatoid arthritis synoviocytes. J Immunol 2001;166:2705–2711.
28. Monaco C, Andreakos E, Kiriakidis S, Mauri C, Bicknell C, Foxwell B, et al. Canonical pathway of nuclear factor k B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis. Proc Natl Acad Sci U S A 2004;101:5634–5639.
29. Zhang YL, Dong C. MAPkinase sinimmuneresponses. Cell Mol Immunol 2005;2:20–27.
30. Vestergaard C, Yoneyama H, Murai M, Nakamura K, Tamaki K, Terashima Y, et al. Overexpression of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 1999;104:1097–1105.
31. Sallusto F, Lenig D, Mackay CR, Lanzaveccchia A. Flexible programs of chemokine receptors expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998;187:875–883.
32. Vestergaard C, Bang K, Gesser B, Yoneyama H, Matsushima K, Larsen CG. A Th2 chemokine, TARC, prouduced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. J Invest Dermatiol 2000;115:640–646.
33. Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001;107:535–541.